Full Text View
Tabular View
No Study Results Posted
Related Studies
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
This study has been completed.
Study NCT00075855   Information provided by National Cancer Institute (NCI)

First Received on January 9, 2004.   Last Updated on February 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer Survivor
Sexual Dysfunction
Sexuality and Reproductive Issues
Additional conditions recognized in this trial
Sexual Dysfunctions, Psychological
More general conditions related to this trial
Mental Disorders
Sexual and Gender Disorders
Interventions listed in this trial
therapeutic testosterone
Additional drug interventions recognized in this trial
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
North Central Cancer Treatment Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services